In vivo pharmacology of SDZ 249-665, a novel, non-pungent capsaicin analogue.
about
Transient receptor potential (TRP) channels as drug targets for diseases of the digestive systemCapsaicin, Nociception and PainThe involvement of TRPV1 in emesis and anti-emesisConversion of acetaminophen to the bioactive N-acylphenolamine AM404 via fatty acid amide hydrolase-dependent arachidonic acid conjugation in the nervous systemModulation of trigeminal sensory neuron activity by the dual cannabinoid-vanilloid agonists anandamide, N-arachidonoyl-dopamine and arachidonyl-2-chloroethylamideDrug-induced mild therapeutic hypothermia obtained by administration of a transient receptor potential vanilloid type 1 agonist.Sensory neurone responses to mucosal noxae in the upper gut: relevance to mucosal integrity and gastrointestinal pain.Acid sensing by visceral afferent neurones.Acid-sensitive ion channels and receptorsChemical nociception in the jejunum induced by capsaicin.Corneal sensitivity following lacrimal gland excision in the rat.Recent developments in transient receptor potential vanilloid receptor 1 agonist-based therapies.Chemosensory properties of the trigeminal system.Menthol activation of corneal cool cells induces TRPM8-mediated lacrimation but not nociceptive responses in rodentsAnti-Hyperuricemic, Anti-Inflammatory and Analgesic Effects of Siegesbeckia orientalis L. Resulting from the Fraction with High Phenolic ContentParadoxic effects of propofol on visceral pain induced by various TRPV1 agonists.The pharmacological challenge to tame the transient receptor potential vanilloid-1 (TRPV1) nocisensorBladder hyperactivity and increased excitability of bladder afferent neurons associated with reduced expression of Kv1.4 alpha-subunit in rats with cystitis.Preferential block of inactivation-deficient Na+ currents by capsaicin reveals a non-TRPV1 receptor within the Na+ channel.Oleoylethanolamide excites vagal sensory neurones, induces visceral pain and reduces short-term food intake in mice via capsaicin receptor TRPV1.Hypersensitivity for capsaicin in patients with functional dyspepsia.
P2860
Q24627020-E40E30E7-21EA-4105-9B1F-F008893AD95FQ26744369-40C7169B-C142-4B49-92C1-74EC8CFD9F88Q26745801-046762A4-F3A5-45D8-8A3E-B358DD481B88Q28182188-5CB751BE-D853-46A2-8698-096312F09849Q28248981-26EF46F6-6E41-4D9D-BB9E-E96A4BEE5338Q33713377-FEEECC70-6400-46CD-A2C2-24BD5626EFEEQ34928837-035FDC9F-F495-4D97-ADBD-2FA44D358C8DQ35177799-D7CD393D-F7E7-4DDE-AF8D-4B75DA28EE1FQ35178189-01C2367D-FBBA-4575-ADD7-7697C83834E7Q35596749-6E0C498F-43B3-446B-93B1-866A3D3D9549Q35678783-AA04E945-D230-4C6C-95BF-76D2FB8F180DQ35925582-101794DE-5C5F-4C54-BCF0-6C8DF1565EA5Q36015318-A25E3900-7848-4997-A86A-87B43D6DCD46Q36318296-372F3584-70BD-4C85-B897-F98207169A41Q36334698-D92BE3EE-688B-40BC-8142-8CC479D46D00Q36771715-9453EDED-2BBC-4A65-89F3-6D227961F4D2Q37023861-5C365678-AEE3-450E-BDA0-9F6345484222Q37210923-AE9B4B9A-B0EA-4E2D-8694-9C1E94E22A6FQ40233976-08C11D56-E387-446D-941B-A4FE1443E1BBQ45253646-B2A3C9DC-8A44-4938-A309-15A1846CB6D4Q46955025-CB353674-68F9-4642-B073-6020FCE915E0
P2860
In vivo pharmacology of SDZ 249-665, a novel, non-pungent capsaicin analogue.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
In vivo pharmacology of SDZ 249-665, a novel, non-pungent capsaicin analogue.
@en
In vivo pharmacology of SDZ 249-665, a novel, non-pungent capsaicin analogue.
@nl
type
label
In vivo pharmacology of SDZ 249-665, a novel, non-pungent capsaicin analogue.
@en
In vivo pharmacology of SDZ 249-665, a novel, non-pungent capsaicin analogue.
@nl
prefLabel
In vivo pharmacology of SDZ 249-665, a novel, non-pungent capsaicin analogue.
@en
In vivo pharmacology of SDZ 249-665, a novel, non-pungent capsaicin analogue.
@nl
P2093
P1433
P1476
In vivo pharmacology of SDZ 249-665, a novel, non-pungent capsaicin analogue.
@en
P2093
B Sandells
E A Campbell
K Buchheit
N Chaudhry
P356
10.1016/S0304-3959(00)00349-3
P407
P577
2000-12-01T00:00:00Z